Ronit Grinbaum
Hebrew University of Jerusalem
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ronit Grinbaum.
International Journal of Cancer | 2012
Aviram Nissan; Alexander Stojadinovic; Stella Mitrani-Rosenbaum; David Halle; Ronit Grinbaum; Marina Roistacher; Andrea Bochem; Baris Emre Dayanc; Gerd Ritter; Ismail Gomceli; Erdal Birol Bostanci; Musa Akoglu; Yao-Tseng Chen; L J Old; Ali O. Gure
Early detection of colorectal cancer (CRC) is currently based on fecal occult blood testing (FOBT) and colonoscopy, both which can significantly reduce CRC‐related mortality. However, FOBT has low‐sensitivity and specificity, whereas colonoscopy is labor‐ and cost‐intensive. Therefore, the discovery of novel biomarkers that can be used for improved CRC screening, diagnosis, staging and as targets for novel therapies is of utmost importance. To identify novel CRC biomarkers we utilized representational difference analysis (RDA) and characterized a colon cancer associated transcript (CCAT1), demonstrating consistently strong expression in adenocarcinoma of the colon, while being largely undetectable in normal human tissues (p < 000.1). CCAT1 levels in CRC are on average 235‐fold higher than those found in normal mucosa. Importantly, CCAT1 is strongly expressed in tissues representing the early phase of tumorigenesis: in adenomatous polyps and in tumor‐proximal colonic epithelium, as well as in later stages of the disease (liver metastasis, for example). In CRC‐associated lymph nodes, CCAT1 overexpression is detectable in all H&E positive, and 40.0% of H&E and immunohistochemistry negative lymph nodes, suggesting very high sensitivity. CCAT1 is also overexpressed in 40.0% of peripheral blood samples of patients with CRC but not in healthy controls. CCAT1 is therefore a highly specific and readily detectable marker for CRC and tumor‐associated tissues.
Annals of Surgery | 2007
Alexander Stojadinovic; Aviram Nissan; Mladjan Protic; Carol F. Adair; Diana Prus; Slavica Usaj; Robin S. Howard; Dragan Radovanovic; Milan Breberina; Craig D. Shriver; Ronit Grinbaum; Jeffery Nelson; Tommy A Brown; Herbert R. Freund; John F. Potter; Tamar Peretz; George E. Peoples
Background:The principal role of sentinel lymph node (SLN) sampling and ultrastaging in colon cancer is enhanced staging accuracy. The utility of this technique for patients with colon cancer remains controversial. Purpose:This multicenter randomized trial was conducted to determine if focused assessment of the SLN with step sectioning and immunohistochemistry (IHC) enhances the ability to stage the regional nodal basin over conventional histopathology in patients with resectable colon cancer. Patients and Methods:Between August 2002 and April 2006 we randomly assigned 161 patients with stage I–III colon cancer to standard histopathologic evaluation or SLN mapping (ex vivo, subserosal, peritumoral, 1% isosulfan blue dye) and ultrastaging with pan-cytokeratin IHC in conjunction with standard histopathology. SLN-positive disease was defined as individual tumor cells or cell aggregates identified by hematoxylin and eosin (H&E) and/or IHC. Primary end point was the rate of nodal upstaging. Results:Significant nodal upstaging was identified with SLN ultrastaging (Control vs. SLN: 38.7% vs. 57.3%, P = 0.019). When SLNs with cell aggregates ≤0.2 mm in size were excluded, no statistically significant difference in node-positive rate was apparent between the control and SLN arms (38.7% vs. 39.0%, P = 0.97). However, a 10.7% (6/56) nodal upstaging was identified by evaluation of H&E stained step sections of SLNs among study arm patients who would have otherwise been staged node-negative (N0) by conventional pathologic assessment alone. Conclusion:SLN mapping, step sectioning, and immunohistochemistry (IHC) identifies small volume nodal disease and improves staging in patients with resectable colon cancer. A prospective trial is ongoing to determine the clinical significance of colon cancer micrometastasis in sentinel lymph nodes.
Journal of The American College of Surgeons | 2009
Haggi Mazeh; Yacov Samet; Bassam Abu-Wasel; Nahum Beglaibter; Ronit Grinbaum; Tzeela Cohen; Meir Pinto; Tamar Hamburger; Herbert R. Freund; Aviram Nissan
BACKGROUND Uniform and accurate reporting of surgical complications is the basis for quality control. We developed a computerized system for reporting and grading surgical complications in colorectal surgery. This study was conducted to evaluate this computerized reporting system. STUDY DESIGN A retrospective chart review was conducted of all surgical complications in patients who underwent resection of the colon or rectum at our institution between the years 1999 and 2004 (n = 408). All complications were recorded using the computerized reporting system and compared with complications reported in the literature. RESULTS Elective operations were performed in 75.7% of patients, and 24.3% required emergency operations. Of the 408 patients in the study, 239 (58.6%) had an uneventful recovery without complications. At least 1 complication was recorded in 169 (41.4%) patients. Grades 1 and 2 complications were recorded in 83 (20.3%) and 105 (25.7%) patients, respectively, requiring observation or medical treatment only, and 59 patients (14.5%) had grades 3 to 5 complications. The three leading complications were surgical site infection, intraabdominal abscess, and hemorrhage requiring blood transfusion. The grades 3 to 5 complication rate was within the range described in the literature, and the rate of grades 1 and 2 complications was substantially higher. These grades 1 and 2 complications were associated with a substantially longer hospital stay. CONCLUSIONS This novel complication reporting system was found feasible and proved to have a higher sensitivity for recording minor but meaningful complications that tend to prolong hospital stay.
Journal of Laparoendoscopic & Advanced Surgical Techniques | 2008
Haggi Mazeh; Nahum Beglaibter; Ronit Grinbaum; Yaacov Samet; Mahmoud Badriyyah; Oded Zamir; Herbert R. Freund
BACKGROUND Laparoscopic hernia repair has been gaining acceptance as an alternative to open repair. The aim of this study was to present the experience of a general surgery ward with laparoscopic inguinal hernia repair. MATERIALS AND METHODS A retrospective search of all laparoscopic inguinal hernia repairs between January 1999 and December 2003 was obtained. Data, including perioperative course, postoperative complication, and long-term follow-up, was documented. RESULTS A total of 423 hernias were repaired in 220 patients. Long-term follow-up was performed by questionnaire, clinic visit, or both in 182 of the 220 patients (82.7%). Median follow-up time was 27.5 (range, 4-61) months. Two hundred and three (92.3%) hernias were bilateral. Fifty-seven patients (25.9%) had recurrent hernias. There was no conversion to an open hernia repair. There were 10 recurrences (2.3%). Minor complications (e.g., abdominal wall hematoma, epigastric vessels injury, and urinary retention requiring catheterization) occurred in 17 (7.7%) patients. A bladder injury occurred in 1 patient (0.45%). There was no mortality. Mean postoperative stay was 1.1 days (range, 1-10). Satisfaction with the laparoscopic repair was expressed by using a scoring system of 1 to 5, with 85.2% being very satisfied (score of 4-5) and 8.2% being dissatisfied (score of 1-2). CONCLUSIONS The laparoscopic herniorrhaphy offers a safe and effective repair with acceptable complication and recurrence rates. Good results with the total extraperitoneal technique can be achieved by general laparoscopists and not only in highly specialized hernia centers. It is especially suited for bilateral repair and for recurrent hernias.
Jsls-journal of The Society of Laparoendoscopic Surgeons | 2012
Roni Zemet; Haggi Mazeh; Ronit Grinbaum; Bassam Abu-Wasel; Nahum Beglaibter
This report emphasizes the importance of performing meticulous closure on all trocar sites 10-mm and greater.
Surgical Endoscopy and Other Interventional Techniques | 2013
Nasser Sakran; David Goitein; Asnat Raziel; Andrei Keidar; Nahum Beglaibter; Ronit Grinbaum; Ibrahim Matter; Ricardo Alfici; Ahmad Mahajna; Igor Waksman; Mordechai Shimonov; Ahmad Assalia
Obesity Surgery | 2014
Ido Mizrahi; Alp Tabak; Ronit Grinbaum; Nahum Beglaibter; Ahmed Eid; Natalia Simanovsky; Nurith Hiller
Obesity Surgery | 2014
Ido Mizrahi; Abbas Al-Kurd; Muhammad Ghanem; Diaa Zugayar; Haggi Mazeh; Ahmed Eid; Nahum Beglaibter; Ronit Grinbaum
Obesity Surgery | 2015
Ido Mizrahi; Nahum Beglaibter; Natalia Simanovsky; Natali Lioubashevsky; Haggi Mazeh; Muhammad Ghanem; Katya Chapchay; Ahmed Eid; Ronit Grinbaum
Obesity Surgery | 2018
Abbas Al-Kurd; Ronit Grinbaum; Ala’a Abubeih; Baha Siam; Muhammad Ghanem; Haggi Mazeh; Ido Mizrahi; Nahum Beglaibter